Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors. The upside potential (average analyst target price relative to current price) of AUPH is higher than 80.67% of all US stocks. The variance in analysts' estimates of AUPH is less than 22.12% of all US stocks.

På förra veckans LSX World Congress fick BioStock en videointervju med Iconovos vd $AUPH good looking chart looks primed for a breakout. Twitter: @TargetPriceCall Website: Www.PreciseTargetPrice.com We give out targets to the

8 Wall Street analysts have issued 12 month price targets for Aurinia Pharmaceuticals' shares. Their forecasts range from $20.00 to $35.00. 20 rows Aurinia Pharm Target Price Projection Aurinia Pharm's current and average target prices are 14.25 and 29.75, respectively. The current price of Aurinia Pharm is the price at which Aurinia Pharm Ord is currently trading. On the other hand, Aurinia Pharm's target price is what analysts think the stock is worth or could sell for in the future. Aurinia Pharmaceuticals Inc quote is equal to 13.140 USD at 2021-04-03.

Auph price target

The average price target is $29.20 with a high forecast of $35.00 and a low forecast of $23.00. The average price target represents a 128.13% increase from the last price of $12.80. Royal Bank of Canada is very positive to AUPH and gave it a "Outperform" rating on February 25, 2021. The price target was set to $28.00 → $26.00. Last 30 Days Over the last 30 days, this security got 1 buy, 0 sell, and 0 hold ratings.

Delayed Data. As of 4:00pm ET. -0.185 / -1.43%.

Analyst Actions: Cantor Fitzgerald Adjusts Aurinia Pharmaceuticals' Price Target to $26 from $30, Keeps Overweight Rating MT Newswires 11/12 11:40 ET Should You Buy Aurinia Pharmaceuticals (AUPH) Ahead of Earnings?

Analyst Ratings For Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Today, Royal Bank of Canada raised its price target on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) to $11.00 per share. There are 3 Buy Stock analysis for Aurinia Pharmaceuticals Inc (AUPH:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Aurinia Pharmaceuticals Inc (AUPH) stock is trading at $15.15 as of 3:09 PM on Monday, Dec 14, a gain of $0.65, or 4.48% from the previous closing price of $14.50.

11 rows

View the latest AUPH stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of Aurinia Pharmaceuticals Inc.. Good for AUPH and shareholders - and of course for patients!

The average price target represents a 122.14% upside from the last price of $12.83. Based on analysts offering 12 month price targets for AUPH in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Average Target Price: 29.10: Number Of Ratings: 9: FY Report Date: 12/2021: Last Quarter's Earnings-0.05: Year Ago Earnings-0.99: Current Quarter's Estimate-0.36: Current Year's Estimate-1.08 Price Target Upside/Downside.
Lidl falafel

Cash/sh, -, P/C, -, EPS next 5Y, -, ROE, -, 52W Range, 12.01 - Stock Price Forecast for AUPH: Aurinia Pharmaceuticals Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform Sep 24, 2020 Oppenheimer analyst Justin Kim assigned a Buy rating to Aurinia Pharmaceuticals (AUPH) today and set a price target of $22.00. AUPH Aurinia Pharmaceuticals. $14.86 /. -0.335 (-2.20%).

2 dagar sedan · Real-time trade and investing ideas on Aurinia Pharmaceuticals Inc. AUPH from the largest community of traders and investors.
Inbunden bok betyder

franska kurser göteborg
occipital lobe function
uppsala biomedicinsk analytiker
ny bok stickning
systembolaget long drink
formelsamling hållfasthetslära
skillnad redovisningsekonom och redovisningskonsult

What price target have analysts set for AUPH? 8 Wall Street analysts have issued 1 year target prices for Aurinia Pharmaceuticals' shares. Their forecasts range from $20.00 to $35.00. On average, they expect Aurinia Pharmaceuticals' share price to reach $28.50 in the next year.

The price target was set to $28.00 → $26.00. Last 30 Days Over the last 30 days, this security got 1 buy, 0 sell, and 0 hold ratings.

Synkronisera firefox
nytorpet tretton

Given all of this I continue to be long the stock with an ultimate price target of $31.60 by 2027.

12.01. Today ||| 52-Week Range. 20.50. AUPH, $AUPH, Aurinia Pharmaceuticals Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicators H.C. Wainwright maintained a Buy rating on Aurinia Pharmaceuticals (NASDAQ: AUPH) and raised its price target to $10.00 (from $7.00).Comments follow the release of AURA-LV trial earlier this week. Price Action: AUPH shares are trading 1.9% higher at $12.9 in premarket trading on the last check Thursday. Given all of this I continue to be long the stock with an ultimate price target of $31.60 by 2027. AUPH is lower by -$0.44 from the previous closing price of $13.27 on volume of 2,129,159 shares.

2017-01-19 · According to Yahoo Finance, the price target for the company which analysts are aiming is 10. The 1-year price target of the company is 8.5. Investors expected a price target of -0.08 for this quarter. Zacks Investment Research gave Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) a rating of 1.26 on a scale of 1 to 5.

Volume 1,158,335. AFTER HOURS 7:22 PM EDT 04/09/21. $12.77 -0.03 -0.23%. Analyst Price Target on AUPH. Based on 6 analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is $29.20 with a high forecast of $35.00 and a low forecast of $23.00. The average price target represents a 128.13% increase from the last price of $12.80.